04:12 PM EST, 12/20/2024 (MT Newswires) -- Marshall Fordyce, Director, President and CEO, on December 18, 2024, sold 17,500 shares in Vera Therapeutics ( VERA ) for $753,680. Following the Form 4 filing with the SEC, Fordyce has control over a total of 307,972 shares of the company, with 85,942 shares held directly and 222,030 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1831828/000141588924029964/xslF345X05/form4-12202024_091238.xml